Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer
Hiroshi Ikeda, Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Hideki Ueno(National Defense Medical College), Yoshikazu Kagami(Tokyo National Hospital), Takuji Okusaka(National Cancer Centre Japan), Atsushi Imai(Osaka International Cancer Institute), M. Ikeda
International Journal of Radiation Oncology*Biology*Physics
September 12, 2003
Cited by 1
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749